MN1 and acute myeloid leukemia: Thus, the study of pre-HSCT BAALC and MN1 expression using ddPCR, together with analysis of the NPM1 mutation and WT1 expression, could be a valid approach to identify AML patients at high risk of early relapse after HSCT.